Organigram Reports Record Fourth Quarter and Fiscal 2025 Results

Core Insights - Organigram Global Inc, Canada's leading recreational cannabis company, reported record financial results for the fourth quarter and fiscal year ending September 30, 2025, highlighting significant growth in revenue and market share [2][4]. Fiscal 2025 Financial Highlights - Gross revenue reached $403.0 million, a 63% increase year-over-year, while net revenue was $259.2 million, up 62% from the previous year [4][6]. - Adjusted EBITDA increased by 160% to $21.9 million, driven by higher recreational cannabis revenue and improved gross margins [4][6]. - The company maintained a 11.9% market share in the Canadian recreational cannabis market [4][6]. Fourth Quarter 2025 Financial Overview - In Q4, gross revenue was $123.3 million, a 76% increase year-over-year, with net revenue rising 79% to $80.1 million [4][6]. - Adjusted gross margin for Q4 was $30.6 million, representing 38% of net revenue, compared to 37% in Q4 Fiscal 2024 [4][6]. - The net loss for Q4 was $38.0 million, a significant increase from a loss of $5.4 million in the same quarter last year, primarily due to non-cash changes in fair value [4][6]. Strategic Initiatives and Acquisitions - The company expanded its capabilities through acquisitions, including Motif Labs Ltd., enhancing its extraction capabilities and market presence [2][4]. - Organigram launched its Fast Acting Soluble Technology (FAST) and entered the U.S. cannabinoid beverages market through the acquisition of Collective Project Limited [4][12]. - The company is focused on operational scale, intellectual property, and market access to support future growth [2][4]. International Growth - Record international revenue reached $26.3 million, a 173% increase year-over-year, reflecting the company's expanding global footprint [4][12]. - The company completed its EU-GMP audit and is awaiting certification confirmation, which will facilitate further international expansion [12][4]. Balance Sheet and Liquidity - As of September 30, 2025, the company had cash, restricted cash, and short-term investments totaling $84.4 million, down from $133.4 million the previous year [9][10]. - Total assets increased by 37% to $562.2 million, while total liabilities rose by 109% to $213.1 million [10][9]. Future Outlook - The company anticipates strong revenue growth in Fiscal 2026, with net revenue expected to exceed $300 million, supported by increasing domestic and international demand [7][4].